Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for ...
Unlocks market access and growth potential of REYOBIQ therapy in recurrent glioblastoma and pediatric brain cancer by ...
Abstract: The deployment of extensive sensor arrays in nuclear reactors is infeasible due to challenging operating conditions and inherent spatial limitations. Strategically placing sensors within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results